Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations

[1]  J. O’Shaughnessy,et al.  The San Antonio Breast Cancer Symposium , 2011 .

[2]  Y. Bek,et al.  A breast cancer nomogram for prediction of non-sentinel node metastasis - validation of fourteen existing models. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[3]  Laurence Collette,et al.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer. , 2015, The New England journal of medicine.

[4]  M. Ross,et al.  Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. , 2001, International journal of radiation oncology, biology, physics.

[5]  R. Gelber,et al.  Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. , 2018, The Lancet. Oncology.

[6]  F. Vicente-García,et al.  Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodes. , 2014, Breast.

[7]  M. Cooperberg,et al.  Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. , 2005, The Journal of urology.

[8]  S. A. Dingemans,et al.  Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population , 2015, Annals of Surgical Oncology.

[9]  Kelly K Hunt,et al.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Yarnold,et al.  Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  K. Kidwell,et al.  Sentinel Lymph Node Frozen-Section Utilization Declines After Publication of American College of Surgeons Oncology Group Z0011 Trial Results With No Change in Subsequent Surgery for Axillary Lymph Node Dissection. , 2016, American journal of clinical pathology.

[12]  R. Mansel,et al.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[13]  E. Steyerberg,et al.  A head to head comparison of nine tools predicting non‐sentinel lymph node status in sentinel node positive breast cancer women , 2015, Journal of surgical oncology.

[14]  M. Sanders,et al.  Decline in Frozen Section Diagnosis for Axillary Sentinel Lymph Nodes as a Result of the American College of Surgeons Oncology Group Z0011 Trial. , 2016, Archives of pathology & laboratory medicine.

[15]  R. Kirby,et al.  Association of One-Step Nucleic Acid Amplification Detected Micrometastases with Tumour Biology and Adjuvant Chemotherapy , 2017, International journal of breast cancer.

[16]  R. Jagsi,et al.  Radiation field design in the ACOSOG Z0011 (Alliance) Trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  M. Morrow,et al.  Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer , 2017, Annals of Surgical Oncology.

[18]  M. Kattan,et al.  Comparisons of nomograms and urologists' predictions in prostate cancer. , 2002, Seminars in urologic oncology.

[19]  F. Su,et al.  Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis , 2013, Breast Cancer Research and Treatment.

[20]  A. Giuliano,et al.  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial , 2017, JAMA.

[21]  J. Bellon,et al.  Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series , 2018, Annals of Surgical Oncology.

[22]  M. Ross,et al.  Incorporation of Sentinel Lymph Node Metastasis Size Into a Nomogram Predicting Nonsentinel Lymph Node Involvement in Breast Cancer Patients With a Positive Sentinel Lymph Node , 2012, Annals of surgery.

[23]  M. Kattan,et al.  Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram , 2005, Annals of Surgical Oncology.

[24]  M. Troxell,et al.  Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer. , 2011, Archives of surgery.

[25]  R. Mansel,et al.  Abstract GS4-01: Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981/22023) , 2019, General Session Abstracts.

[26]  M. Morrow,et al.  Estrogen Receptor, Progesterone Receptor, and HER2 Status Predict Lymphovascular Invasion and Lymph Node Involvement , 2014, Annals of Surgical Oncology.

[27]  H. Ashamalla,et al.  Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry , 2015, Journal of breast cancer.

[28]  T. Whelan,et al.  Regional Nodal Irradiation in Early-Stage Breast Cancer. , 2015, The New England journal of medicine.

[29]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.